Prognostic and clinicopathological insights of phosphodiesterase 9A gene as novel biomarker in human colorectal cancer

[11] Hasnat A(2018)Effectiveness of screening colonoscopy in reducing the risk of death from right and left colon cancer: a large community-based study Gut 67 291-3454

[12] Raza AM(2007)Colorectal cancer: a model for epigenetic tumorigenesis Gut 56 140-1595

[13] Kamal M(2004)Methylation profile of the promoter CpG islands of 31 genes that may contribute to colorectal carcinogenesis World J Gastroenterol: WJG 10 3441-6

[14] Begum F(2008)Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US multi-society task force on colorectal Cancer, and the American College of Radiology Gastroenterology 134 1570-2496

[15] Yusuf MA(2014)The diagnostics of colorectal cancer Contemp Oncol 18 1-19

[16] Mohammad D(2015)Promoter hypermethylation of tumour suppressor genes as potential biomarkers in colorectal cancer Int J Mol Sci 16 2472-233

[17] Begum M(2017)Predictive and prognostic biomarkers in colorectal cancer: a systematic review of recent advances and challenges Biomed Pharmacother 87 8-392

[18] Talukder AR(2014)Clinical and molecular genetics of the phosphodiesterases (PDEs) Endocr Rev 35 195-476

[19] Kobaek-Larsen M(1998)Identification and characterization of a novel cyclic nucleotide phosphodiesterase gene (PDE9A) that maps to 21q22. 3: alternative splicing of mRNA transcripts, genomic structure and sequence Hum Genet 103 386-11

[20] Thorup I(2015)Phosphodiesterase 9A controls nitric-oxide-independent cGMP and hypertrophic heart disease Nature 519 472-131

[11] Hasnat A(2018)Effectiveness of screening colonoscopy in reducing the risk of death from right and left colon cancer: a large community-based study Gut 67 291-3454

[12] Raza AM(2007)Colorectal cancer: a model for epigenetic tumorigenesis Gut 56 140-1595

[13] Kamal M(2004)Methylation profile of the promoter CpG islands of 31 genes that may contribute to colorectal carcinogenesis World J Gastroenterol: WJG 10 3441-6

[14] Begum F(2008)Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US multi-society task force on colorectal Cancer, and the American College of Radiology Gastroenterology 134 1570-2496

[15] Yusuf MA(2014)The diagnostics of colorectal cancer Contemp Oncol 18 1-19

[16] Mohammad D(2015)Promoter hypermethylation of tumour suppressor genes as potential biomarkers in colorectal cancer Int J Mol Sci 16 2472-233

[17] Begum M(2017)Predictive and prognostic biomarkers in colorectal cancer: a systematic review of recent advances and challenges Biomed Pharmacother 87 8-392

[18] Talukder AR(2014)Clinical and molecular genetics of the phosphodiesterases (PDEs) Endocr Rev 35 195-476

[19] Kobaek-Larsen M(1998)Identification and characterization of a novel cyclic nucleotide phosphodiesterase gene (PDE9A) that maps to 21q22. 3: alternative splicing of mRNA transcripts, genomic structure and sequence Hum Genet 103 386-11

[20] Thorup I(2015)Phosphodiesterase 9A controls nitric-oxide-independent cGMP and hypertrophic heart disease Nature 519 472-131